MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice

This publication has 33 references indexed in Scilit:

• The origin and function of tumor-associated macrophages
  Immunology Today, 1992
• Prophylactic activity against Sendai virus infection and macrophage activation with lipophilic derivatives of N-acetylglucosaminylmuramyl tri- or tetrapeptides
  Vaccine, 1989
• Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon γ followed by an analogue (GLA-60) to synthetic lipid A subunit
  Cancer Immunology, Immunotherapy, 1989
• Murine Liver Metastasis Model Using L5178Y‐ML Lymphoma and the Effect of Antitumor Agents on the Metastasis
  Japanese Journal of Cancer Research, 1988
• Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues
  Vaccine, 1988
• Lymphokines and monokines in the clinic
  Immunology Today, 1986
• Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
  The Journal of Experimental Medicine, 1984
• T‐T cell interactions during in vitro cytotoxic T lymphocyte responses. III. Antigen‐specific T helper cells release nonspecific mediator(s) able to help induction of H‐2‐restricted cytotoxic T lymphocyte responses across cell‐impermeable membranes
  European Journal of Immunology, 1980
• Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
  Biochemical and Biophysical Research Communications, 1974
• Adjuvant activity of monomeric bacterial cell wall peptidoglycans
  Biochemical and Biophysical Research Communications, 1974